Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss

被引:105
作者
Xiong, Jinhu [1 ,2 ]
Cawley, Keisha [1 ,3 ]
Piemontese, Marilina [3 ]
Fujiwara, Yuko [3 ]
Zhao, Haibo [3 ]
Goellner, Joseph J. [1 ,3 ,4 ]
O'Brien, Charles A. [1 ,2 ,3 ,4 ]
机构
[1] Univ Arkansas Med Sci, Ctr Musculoskeletal Dis Res, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA
基金
美国国家卫生研究院;
关键词
TUMOR-NECROSIS-FACTOR; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; OSTEOPROTEGERIN-LIGAND; CELLS; TNF; DIFFERENTIATION; IDENTIFICATION; REGULATOR; OSTEOCYTE;
D O I
10.1038/s41467-018-05244-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Receptor activator of NFkB ligand (RANKL) is a TNF-family cytokine required for osteoclast formation, as well as immune cell and mammary gland development. It is produced as a membrane-bound protein that can be shed to form a soluble protein. We created mice harboring a sheddase-resistant form of RANKL, in which soluble RANKL is undetectable in the circulation. Lack of soluble RANKL does not affect bone mass or structure in growing mice but reduces osteoclast number and increases cancellous bone mass in adult mice. Nonetheless, the bone loss caused by estrogen deficiency is unaffected by the lack of soluble RANKL. Lymphocyte number, lymph node development, and mammary gland development are also unaffected by the absence of soluble RANKL. These results demonstrate that the membrane-bound form of RANKL is sufficient for most functions of this protein but that the soluble form does contribute to physiological bone remodeling in adult mice.
引用
收藏
页数:7
相关论文
共 30 条
[1]   Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation [J].
Chen, Chun-Hsiung ;
Chen, Hung-An ;
Liao, Hsien-Tzung ;
Liu, Chin-Hsiu ;
Tsai, Chang-Youh ;
Chou, Chung-Tei .
CLINICAL RHEUMATOLOGY, 2010, 29 (10) :1155-1161
[2]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[3]   The Osteocyte: An Endocrine Cell . . . and More [J].
Dallas, Sarah L. ;
Prideaux, Matthew ;
Bonewald, Lynda F. .
ENDOCRINE REVIEWS, 2013, 34 (05) :658-690
[4]   The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development [J].
Fata, JE ;
Kong, YY ;
Li, J ;
Sasaki, T ;
Irie-Sasaki, J ;
Moorehead, RA ;
Elliott, R ;
Scully, S ;
Voura, EB ;
Lacey, DL ;
Boyle, WJ ;
Khokha, R ;
Penninger, JM .
CELL, 2000, 103 (01) :41-50
[5]   Secondary osteons scale allometrically in mammalian humerus and femur [J].
Felder, A. A. ;
Phillips, C. ;
Cornish, H. ;
Cooke, M. ;
Hutchinson, J. R. ;
Doube, M. .
ROYAL SOCIETY OPEN SCIENCE, 2017, 4 (11)
[6]   RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice [J].
Fujiwara, Yuko ;
Piemontese, Marilina ;
Liu, Yu ;
Thostenson, Jeff D. ;
Xiong, Jinhu ;
O'Brien, Charles A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (48) :24838-24850
[7]   The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction [J].
Geusens, P. P. ;
Landewe, R. B. M. ;
Garnero, P. ;
Chen, D. ;
Dunstan, C. R. ;
Lems, W. F. ;
Stinissen, P. ;
van der Heijde, D. M. F. M. ;
van der Linden, S. ;
Boers, M. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1772-1777
[8]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802
[9]  
Grignani F, 1998, CANCER RES, V58, P14
[10]   Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding [J].
Hikita, A ;
Kadono, Y ;
Chikuda, H ;
Fukuda, A ;
Wakeyama, H ;
Yasuda, H ;
Nakamura, K ;
Oda, H ;
Miyazaki, T ;
Tanaka, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) :41700-41706